This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kalakonda, S. Articles by Kalvakolanu, D. V. Search for Related Content PubMed PubMed Citation Articles by Kalakonda, S. Articles by Kalvakolanu, D. V.

Tumor-Suppressive Activity of the Cell Death Activator GRIM-19 on a Constitutively Active Signal Transducer and Activator of Transcription 3

¹ Department of Microbiology and Immunology, Greenebaum Cancer Center, University of Maryland School of Medicine; ² Department of Environmental Health Sciences, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland; and ³ Taussig Cancer Center, The Cleveland Clinic Foundation, Cleveland, Ohio

Requests for reprints: Dhananjaya V. Kalvakolanu, University of Maryland Cancer Center, Howard Hall, Room 324, 660 W. Redwood Street, Baltimore, MD 21201. Phone: 410-328-1396; Fax: 410-328-6559; E-mail: dkalvako{at}umaryland.edu.

Signal transducers and activators of transcription 3 (STAT3) was originally identified as a transcription factor that mediates cytokine-induced responses. In these pathways, Janus-activated kinase (JAK)–induced transient tyrosine phosphorylation of STAT3 promotes gene expression in response to a number of cytokines, which is inhibited by feedback mechanisms. A number of studies have shown that STAT3 is constitutively activated in human cancer cells, leading to cell proliferation. It is unclear, apart from a chronic tyrosyl phosphorylation of STAT3, what mechanisms contribute to the STAT3 deregulation in tumors. Earlier, we have isolated a novel growth inhibitory gene product, gene associated with retinoid-IFN–induced mortality 19 (GRIM-19), using a genetic approach. GRIM-19 is an IFN/retinoic acid–regulated growth suppressor. Subsequent analyses have shown that GRIM-19 binds to STAT3 and prevents interleukin-6–induced transcription of cellular genes. However, its effects on a constitutively active STAT3 and cellular transformation are unknown. In this study, we show that GRIM-19 suppresses constitutive STAT3-induced cellular transformation in vitro and in vivo by down-regulating the expression of a number of cellular genes involved in cell proliferation and apoptosis. [Cancer Res 2007;67(13):6212–20]

This article has been cited by other articles:

				H. Li, P. Gade, S. C. Nallar, A. Raha, S. K. Roy, S. Karra, J. K. Reddy, S. P. Reddy, and D. V. Kalvakolanu The Med1 Subunit of Transcriptional Mediator Plays a Central Role in Regulating CCAAT/Enhancer-binding Protein-{beta}-driven Transcription in Response to Interferon-{gamma} J. Biol. Chem., May 9, 2008; 283(19): 13077 - 13086. [Abstract] [Full Text] [PDF]

				H. Lu and X. Cao GRIM-19 Is Essential for Maintenance of Mitochondrial Membrane Potential Mol. Biol. Cell, May 1, 2008; 19(5): 1893 - 1902. [Abstract] [Full Text] [PDF]

				P. Gade, S. K. Roy, H. Li, S. C. Nallar, and D. V. Kalvakolanu Critical Role for Transcription Factor C/EBP-{beta} in Regulating the Expression of Death-Associated Protein Kinase 1 Mol. Cell. Biol., April 15, 2008; 28(8): 2528 - 2548. [Abstract] [Full Text] [PDF]

				S. Kalakonda, S. C. Nallar, P. Gong, D. J. Lindner, S. E. Goldblum, S. P. Reddy, and D. V. Kalvakolanu Tumor Suppressive Protein Gene Associated with Retinoid-Interferon-Induced Mortality (GRIM)-19 Inhibits src-Induced Oncogenic Transformation at Multiple Levels Am. J. Pathol., October 1, 2007; 171(4): 1352 - 1368. [Abstract] [Full Text] [PDF]